3D-QSAR studies of xanthone derivatives as human alpha glucosidase inhibitors

International Journal of Integrative Biology

Volumn 5, Issue 1, 2009, Pages 13-19

  Saqib, Uzma ^a   Siddiqi, Mohammad Imran ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

CoMFA; CoMSIA; Human alpha glucosidase; Type 2 diabetes mellitus; Xanthones

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; XANTHONE DERIVATIVE;

ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; MOLECULAR DOCKING; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; VALIDATION PROCESS;

EID: 70249092964     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boehringer Ingelheim (2007) Annual Report. Page: 38.
2. Braun C, Brayer GD et al.(1995) Mechanism-based inhibition of yeast alpha-glucosidase and human pancreatic alpha-amylase by a new class of inhibitors, 2-Deoxy-2,2-difluoro-alpha-glycosides. J. Biol. Chem. 270(45):26778-26781.
3. Bush BL, Nachbar RB Jr. (1993) Sample-distance Partial Least Squares: PLS optimized for many variables, with application to CoMFA. J. Comput. Aded Mol. Des. 7(5):587-619.
4. 2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. J. Med. Chem. 38: 1060-1066.
5. Clark M, Cramer III RD, et al.(1989) Validation of the general purpose tripos 5.2 force field. J. Comput. Chem. 10:982-1012.
6. Clark M, Cramer III RD, et al.(1990) Comparative molecular field analysis (CoMFA) Toward its use with 3D structural databases. Tetrahedron Comput. Methodol. 3: 47-59.
7. Cramer RD, Patterson DE, et al.(1988) Comparative molecular-field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110:5959-5967.
8. Cramer RD, Bunce JD, et al.(1988) Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant Struct Act Relat. 7: 18-25.
9. Das SK, Chakrabarti R (2005) Non-Insulin Dependent Diabetes Mellitus: Present Therapies and New Drug Targets. Mini Reviews in Medicinal Chemistry 5(11): 1019-1034.
10. Dwek RA, Butters TD. et al.(2002) Targetting glycosylation as a therapeutic approach. Nat. Rev. Drug Disc. 1:65-75.
11. Gao H, Kawabata J (2005) α-Glucosidase inhibition of 6- hydroxyflavones. Part 3: Synthesis and evaluation of 2,3,4- trihydroxybenzoyl-containing flavonoid analogs and 6-aminoflavones as a-glucosidase inhibitors. Bioorganic & Macinal Chemistry 13(5):1661-1671.
12. Gohlke H, Hendlich M, et al. (2000) Knowledge-based Scoring Function to Predict Protein-Ligand Interactions. J. Mol. Biol. 295:337-356.
13. Hai-Wei X. Gui-Fu D, et al. (2007) Synthesis of andrographolide derivatives: A new family of α-glucosidue inhibitors. Bioorganic & Medicinal Chemistry 15(12):4247-4255.
14. Insight II 2000.1 Program (2000) Accelrys, San Diego, CA.
15. International Diabetes Federation. Diabetes Atlas. 3rd edn. Brussels: International Diabetes Federation, 2006.
16. Klebe G, Abraham U, et al.(1994) Molecular similarity indexes in a comparative-analysis (Comsia) of drug molecules to correlate and prediatheir biological -activity. J. Mod. Chem. 37(24): 4130-4146.
17. Lajola FM, Filho JM, et al. (1984) Effect of a bean (Phaseolus vulgaris) Alpha.-amylase inhibitor on starch utilization. Nutrition Reports International. 30(1):45-54.
18. Liu Y, Zou L, et al. (2006) Synthesis and pharmacological activities of xanthone derivatives as α-glucosidase inhibitors. Bioorganic & Medicinal Chemistry 14(16): 5683-5690.
19. Liu Y, Ma L, et al. (2007) Synthesis of xanthone derivatives with extended π-systems as α-glucosidase inhibitors: Insight into the probable binding mode. Bioorganic & Medicinal Chemistry. 5(8): 2810-2814.
20. Madariaga H, Lee PC, et al. (1998) Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo. Dig Dis And Sci. 33(8):1020-1024.
21. Matsuuraa H, Miyazakia H, et al. (2004) Isolation of α-glucosidase inhibitors from hyssop (Hyssopus offcinalis). Phytochemistry, 65(1):91-97.
22. McCulloch DK, Kurtz AB et al. (1993) A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care 6(5):483-487.
23. Melo E.B., Gomes A.S. et al. (2006). α- and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron. 62(44):10277-10302.
24. Rarey M, Kramer B, et al.(1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261(3):470-89.
25. Robinson KM, Begovic ME, et al. (1991) New potent α-glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes 40(7):825-830.
26. Saqib U, Siddiqi MI (2008) Probing ligand binding interactions of human alpha glucosidase by homology modeling and molecular docking. International Journal of Integrative Biology. 2(2):116-121.
27. Seo EJ, Curtis-Long MJ, et al. (2007) Xanthones from Cudrania Tricuspidata displaying potent α-glucosidase inhibition. Bioorganic & Medicinal Chemistry Letters 17:6421-6424.
28. Stable L, Wold S, et al. (1988) Multivariate data analysis and experimental design in biomedical research Elsevier Science Publisher. 25:292-338.
29. SYBYL Molecular Modeling System Version 7.1 (2005) Tripos Inc., St. Louis, MO.
30. Truscheit E, Frommer W et al. (1981) Chemistry and Biochemistry of Microbial α-Glucosidase Inhibitors. Angew Chem Int. Ed Engl 20(9):744-761.
31. Viswanadhan VN, Ghose AK, et al. (1989) J. Chem. Inf. Comput. Sci. 29(3):163-172.
32. Wold S (1978) Cross-validation estimation of the number of components in factor and principal components analysis. Technometrics 24: 397-405.
33. World Health Organisation. Fact Sheet No. 312: What is Diabetes?. Available at:http://www.who.int/mediacentre/factsheets/fs312/en/.